Reduced SPOP expression, along with elevated TWIST1 levels, is associated with poor prognosis in advanced breast cancer patients, particularly those with metastatic triple-negative breast cancer (TNBC). This evidence concerns the gene TWIST1 and triple-negative breast carcinoma.